Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease

Current guidelines recommend aspirin, statins, angiotensin-converting enzyme inhibitors (ACEIs), and smoking abstinence for all patients with vascular disease. There is little data on the variation in adherence to guideline-recommended therapies among patients with different clinical manifestations...

Full description

Saved in:

Bibliographic Details
Published in:	Vascular health and risk management Vol. 11; no. default; pp. 185 - 193
Main Authors:	Chen, Debbie, Armstrong, Ehrin, Singh, Gagan, Amsterdam, Ezra, Laird, John
Format:	Journal Article
Language:	English
Published:	New Zealand Dove Medical Press Limited 01.01.2015 Taylor & Francis Ltd Dove Press Dove Medical Press
Subjects:	Aged Angiotensin-Converting Enzyme Inhibitors - therapeutic use Aspirin Aspirin - therapeutic use Blood circulation disorders California Cardiology Cardiovascular disease Care and treatment Carotid arteries Cholesterol Chronic obstructive pulmonary disease Collaboration Coronary vessels Data collection Diabetes Enzymes Evaluation Female Forecasts and trends Guideline Adherence Health risk assessment Heart attacks Heart failure Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypertension Ischemia Male Medical imaging Medical prognosis Middle Aged Mortality Original Research Patient compliance Patients peripheral arterial disease Peripheral Arterial Disease - complications Peripheral Arterial Disease - diagnosis Peripheral Arterial Disease - mortality Peripheral Arterial Disease - therapy Platelet Aggregation Inhibitors - therapeutic use Practice guidelines (Medicine) Practice Guidelines as Topic Practice Patterns, Physicians' - standards Registries Retrospective Studies Risk Factors secondary prevention Secondary Prevention - methods Smoking - adverse effects Smoking - mortality Smoking Cessation Smoking Prevention statin medications Statins Stroke United States > US California statin medications peripheral arterial disease secondary prevention
ISSN:	1178-2048, 1176-6344, 1178-2048
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!